Qube Research & Technologies Ltd: CXM position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Qube Research & Technologies Ltd on CXM, newest first. How the timeline and the estimate are built.
Qube Research & Technologies Ltd held 2,179,052 CXM shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 2,179,052 sharesChange vs previous 13F +1,970,156 shares
0.01% of the 13F portfolio, value $11,243,908.
13F-HR 0001729829-26-000014 filed by Qube Research & Technologies Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 208,896 sharesChange vs previous 13F -461,875 shares
<0.01% of the 13F portfolio, value $1,253,376.
13F-HR 0001729829-26-000004 filed by Qube Research & Technologies Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 670,771 sharesChange vs previous 13F +545,167 shares
0.01% of the 13F portfolio, value $5,218,598.
13F-HR 0001729829-26-000002 filed by Qube Research & Technologies Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 125,604 sharesChange vs previous 13F +40,202 shares
<0.01% of the 13F portfolio, value $969,663.
13F-HR 0001729829-25-000053 filed by Qube Research & Technologies Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 85,402 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $722,501.
13F-HR 0001729829-25-000050 filed by Qube Research & Technologies Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).